March 24, 2014

PHARMAQ and the Ministry of Agriculture and Rural Development in Vietnam signed an agreement of cooperation in vaccine development for several different farmed fish species.

"This agreement gives PHARMAQ a strong basis for further development of vaccines for pangasius and other farmed species in Vietnam. This strengthens the company's possibilities to develop high-technology products based on knowledge from Norway in close cooperation with Norwegian and Vietnamese research teams. By signing this agreement of cooperation we take an important step further in a common goal of a forward-looking, sustainable Vietnamese fish farming industry," said Morten K. Nordstad, chief executive officer of PHARMAQ.

PHARMAQ was first engaged in development of fish vaccines for Vietnam in 2006. Since 2008 the company has been present through its own subsidiary, PHARMAQ Vietnam, with a total of 18 employees today.

In April 2013, PHARMAQ received the marketing authorisation for the first vaccine in Vietnam, which also represented the first time ever the fish farming nation Vietnam registered a vaccine for fish. This vaccine, targeting the most important farmed fish species, pangasius, was tested and documented in 2009 to 2010 through field trials conducted in Vietnam.

PHARMAQ is the world's leading pharmaceutical company supplying the aquaculture industry. The company's products are marketed in Europe, North and South America, and Asia.